Lindbrook Capital, LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 62 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q2 2024$6,102
+1.5%
1420.0%0.00%0.0%
Q1 2024$6,012
+1.3%
1420.0%0.00%0.0%
Q4 2023$5,933
+314.0%
142
+273.7%
0.00%
Q3 2023$1,433
-0.6%
380.0%0.00%
Q2 2023$1,441
-47.6%
38
-66.4%
0.00%
Q1 2023$2,748
-61.1%
113
-53.5%
0.00%
-100.0%
Q4 2022$7,057
+41.1%
243
+34.3%
0.00%0.0%
Q3 2022$5,000
+150.0%
181
+182.8%
0.00%
Q2 2022$2,0000.0%64
+45.5%
0.00%
Q1 2022$2,000
-92.0%
44
-91.3%
0.00%
-100.0%
Q4 2021$25,000
-37.5%
506
-19.4%
0.00%
-60.0%
Q3 2021$40,000
-14.9%
628
-3.1%
0.01%
-9.1%
Q2 2021$47,0000.0%648
+0.8%
0.01%0.0%
Q1 2021$47,0000.0%6430.0%0.01%0.0%
Q4 2020$47,000
+571.4%
643
+431.4%
0.01%
+450.0%
Q3 2020$7,000
-36.4%
121
-26.2%
0.00%
-33.3%
Q2 2020$11,000
-42.1%
164
-46.9%
0.00%
-57.1%
Q1 2020$19,000
+850.0%
309
+1445.0%
0.01%
+600.0%
Q4 2019$2,0000.0%200.0%0.00%0.0%
Q3 2019$2,000200.00%
Q4 2018$000.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Claret Asset Management Corp 94,031$10,164,0002.02%
ALTERNA WEALTH MANAGEMENT, INC 20,530$2,219,0001.88%
Strategic Global Advisors, LLC 72,308$7,816,0001.64%
Analyst IMS Investment Management Services Ltd. 28,438$3,074,0000.95%
Freestone Capital Holdings, LLC 129,757$14,025,0000.83%
Hudson Capital Management LLC 12,394$1,339,667,0000.82%
FORT, L.P. 19,158$2,071,0000.42%
MENTA CAPITAL LLC 6,880$744,0000.32%
Empirical Finance, LLC 9,511$1,028,0000.26%
ALGERT GLOBAL LLC 4,071$440,0000.25%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders